What is he best known for?
The fields of study he is best known for:
- Organic chemistry
- Enzyme
- DNA
Ronald G. Harvey mostly deals with Stereochemistry, Organic chemistry, Pyrene, Carcinogen and Benzopyrene.
His Stereochemistry study incorporates themes from Adduct, Nucleotide and Binding site.
His Pyrene research includes themes of Nucleophile and DNA.
His Carcinogen research incorporates elements of Aldo-keto reductase, Toxicology, A549 cell, Anthracene and Metabolite.
His Benzopyrene research includes elements of Epoxide, RNA, Chemical synthesis, In vivo and Metabolism.
His study looks at the intersection of Epoxide and topics like Diol with Deoxyribonucleoside.
His most cited work include:
- Benzo(a)pyrene diol epoxides as intermediates in nucleic acid binding in vitro and in vivo. (534 citations)
- Structures of benzo(a)pyrene–nucleic acid adducts formed in human and bovine bronchial explants (263 citations)
- Dehydrogenation of polycyclic hydroaromatic compounds (232 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Stereochemistry, Organic chemistry, Carcinogen, Pyrene and Epoxide.
His study in Stereochemistry is interdisciplinary in nature, drawing from both Covalent bond, DNA, Anthracene, Chrysene and Adduct.
His research in Anthracene focuses on subjects like Medicinal chemistry, which are connected to Ring.
The concepts of his Carcinogen study are interwoven with issues in Biological activity, DMBA, 7,12-Dimethylbenz[a]anthracene, Metabolite and Methyl group.
A large part of his Pyrene studies is devoted to Benzopyrene.
His study brings together the fields of Diol and Epoxide.
He most often published in these fields:
- Stereochemistry (40.08%)
- Organic chemistry (33.13%)
- Carcinogen (26.58%)
What were the highlights of his more recent work (between 1996-2016)?
- Carcinogen (26.58%)
- Organic chemistry (33.13%)
- Stereochemistry (40.08%)
In recent papers he was focusing on the following fields of study:
Ronald G. Harvey spends much of his time researching Carcinogen, Organic chemistry, Stereochemistry, Epoxide and Anthracene.
His Carcinogen research is multidisciplinary, incorporating perspectives in Metabolite, Active metabolite, 7,12-Dimethylbenz[a]anthracene and Pyrene.
Many of his studies on Pyrene apply to Guanine as well.
Ronald G. Harvey has researched Stereochemistry in several fields, including Adduct, Polycyclic aromatic hydrocarbon, DNA and Benzopyrene.
In his study, which falls under the umbrella issue of Benzopyrene, Metabolism is strongly linked to Cell culture.
His Epoxide research is multidisciplinary, incorporating elements of Diol and Picene.
Between 1996 and 2016, his most popular works were:
- Activation of polycyclic aromatic hydrocarbon trans-dihydrodiol proximate carcinogens by human aldo-keto reductase (AKR1C) enzymes and their functional overexpression in human lung carcinoma (A549) cells. (174 citations)
- Synthesis of polycyclic xanthenes and furans via palladium-catalyzed cyclization of polycyclic aryltriflate esters (88 citations)
- Evidence for the aldo-keto reductase pathway of polycyclic aromatic trans-dihydrodiol activation in human lung A549 cells (87 citations)
In his most recent research, the most cited papers focused on:
- Organic chemistry
- Enzyme
- Catalysis
The scientist’s investigation covers issues in Carcinogen, Benzopyrene, Pyrene, Biochemistry and Organic chemistry.
His studies in Carcinogen integrate themes in fields like DNA, Anthracene, Enzyme, Metabolite and Stereochemistry.
He has included themes like Epoxide hydrolase and Polycyclic aromatic hydrocarbon in his Stereochemistry study.
The Benzopyrene study combines topics in areas such as Cell culture, Chromatography, Deoxyguanosine and Epoxide.
His Epoxide research integrates issues from Diol, Dado and Chemical synthesis.
His Pyrene study frequently draws connections to adjacent fields such as Adduct.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
